Oral Antifibrotic Agents for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease marked by a decline in forced vital capacity (FVC). While nintedanib and pirfenidone are standard treatments, the benefits of newer drugs like nerandomilast and combination therapies remain unclear. This study employed a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yoichi Tagami, Motoki Kawai, Ken Okamura, Hideya Kitamura
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Gleam Publishing 2025-07-01
coleção:	Journal of Clinical Question
Assuntos:	idiopathic pulmonary fibrosis antifibrotic therapy nintedanib pirfenidone nerandomilast network meta-analysis
Acesso em linha:	https://jclinque.com/article/oral-antifibrotic-agents-for-the-treatment-of-idiopathic-pulmonary-fibrosis-a-systematic-review-and-network-meta-analysis-of-randomized-controlled-trials
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!